{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:16:03Z","timestamp":1778786163550,"version":"3.51.4"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>The study investigates the prognostic impact of the prothrombin time\/international normalized ratio (PT\/INR) in patients with cardiogenic shock.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Despite ongoing improvements regarding the treatment of cardiogenic shock patients, intensive care unit (ICU)-related mortality in cardiogenic shock patients remains unacceptably high. Limited data regarding the prognostic value of the PT\/INR during the course of cardiogenic shock treatment is available.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>All consecutive patients with cardiogenic shock from 2019 to 2021 were included at one institution. Laboratory values were collected from the day of disease onset (day 1) and days 2, 3, 4 and 8. The prognostic impact of the PT\/INR was tested for 30-day all-cause mortality, as well as the prognostic role of PT\/INR changes during course of ICU hospitalization. Statistical analyses included univariable <jats:italic toggle=\"yes\">t<\/jats:italic>-test, Spearman\u2019s correlation, Kaplan\u2013Meier analyses, C-Statistics and Cox proportional regression analyses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Two hundred twenty-four cardiogenic shock patients were included with a rate of all-cause mortality at 30\u2005days of 52%. The median PT\/INR on day 1 was 1.17. The PT\/INR on day 1 was able to discriminate 30-day all-cause mortality in cardiogenic shock patients [area under the curve 0.618; 95% confidence interval (CI), 0.544\u20130.692; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.002). Patients with PT\/INR\u2005&gt;\u20051.17 were associated with an increased risk of 30-day mortality [62% vs. 44%; hazard ratio (HR)\u2005=\u20051.692; 95% CI, 1.174\u20132.438; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.005], which was still evident after multivariable adjustment (HR\u2005=\u20051.551; 95% CI, 1.043\u20132.305; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.030). Furthermore, especially patients with an increment of the PT\/INR by \u226510% from day 1 to day 2 were associated with an increased risk of 30-day all-cause mortality (64% vs. 42%; log-rank <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.014; HR\u2005=\u20051.833; 95% CI, 1.106\u20133.038; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.019).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Baseline PT\/INR and an increase of the PT\/INR during the course of ICU treatment were associated with the risk of 30-day all-cause mortality in cardiogenic shock patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000001241","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T03:02:15Z","timestamp":1683169335000},"page":"395-403","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["The prothrombin time\/international normalized ratio predicts prognosis in cardiogenic shock"],"prefix":"10.1097","volume":"34","author":[{"given":"Tobias","family":"Schupp","sequence":"first","affiliation":[{"name":"Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University"},{"name":"European Center for AngioScience (ECAS) and German Center for Cardiovascular Research (DZHK) Partner Site Heidelberg\/Mannheim, Mannheim"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Behnes","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University"},{"name":"European Center for AngioScience (ECAS) and German Center for Cardiovascular Research (DZHK) Partner Site Heidelberg\/Mannheim, Mannheim"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Rusnak","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University"},{"name":"European Center for AngioScience (ECAS) and German Center for Cardiovascular Research (DZHK) Partner Site Heidelberg\/Mannheim, Mannheim"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Dudda","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University"},{"name":"European Center for AngioScience (ECAS) and German Center for Cardiovascular Research (DZHK) Partner Site Heidelberg\/Mannheim, Mannheim"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Forner","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University"},{"name":"European Center for AngioScience (ECAS) and German Center for Cardiovascular Research (DZHK) Partner Site Heidelberg\/Mannheim, Mannheim"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marinela","family":"Ruka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University"},{"name":"European Center for AngioScience (ECAS) and German Center for Cardiovascular Research (DZHK) Partner Site Heidelberg\/Mannheim, Mannheim"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sascha","family":"Egner-Walter","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University"},{"name":"European Center for AngioScience (ECAS) and German Center for Cardiovascular Research (DZHK) Partner Site Heidelberg\/Mannheim, Mannheim"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bertsch","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, Nuremberg General Hospital, Paracelsus Medical University, Nuremberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Clinic for Interventional Electrophysiology, Heart Centre Bad Neustadt, Bad Neustadt a. d. Saale"},{"name":"Department of Cardiology and Angiology, Philipps-University Marburg, Marburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Akin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University"},{"name":"European Center for AngioScience (ECAS) and German Center for Cardiovascular Research (DZHK) Partner Site Heidelberg\/Mannheim, Mannheim"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,5,1]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.2021.18323","article-title":"Cardiogenic shock after acute myocardial infarction: a review.","volume":"326","author":"Samsky","year":"2021","journal-title":"JAMA"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1001\/jama.297.17.1892","article-title":"Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006.","volume":"297","author":"Fox","year":"2007","journal-title":"JAMA"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/eurheartj\/ehz363","article-title":"Management of cardiogenic shock complicating myocardial infarction: an update 2019.","volume":"40","author":"Thiele","year":"2019","journal-title":"Eur Heart J"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJMoa1808788","article-title":"One-year outcomes after PCI strategies in cardiogenic shock.","volume":"379","author":"Thiele","year":"2018","journal-title":"N Engl J Med"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association.","volume":"136","author":"van Diepen","year":"2017","journal-title":"Circulation"},{"key":"R6-20250729","first-page":"183","article-title":"Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: a document of the Acute Cardiovascular Care Association of the European Society of Cardiology.","volume":"9","author":"Zeymer","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1161\/CIRCULATIONAHA.120.048792","article-title":"Left ventricular unloading is associated with lower mortality in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation: results from an international, multicenter cohort study.","volume":"142","author":"Schrage","year":"2020","journal-title":"Circulation"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1161\/CIRCULATIONAHA.118.038201","article-title":"Intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction: long-term 6-year outcome of the randomized IABP-SHOCK II Trial.","volume":"139","author":"Thiele","year":"2019","journal-title":"Circulation"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jacc.2018.11.038","article-title":"Venoarterial ECMO for adults: JACC Scientific Expert Panel.","volume":"73","author":"Guglin","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1093\/eurheartj\/ehab110","article-title":"The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction.","volume":"42","author":"Ceglarek","year":"2021","journal-title":"Eur Heart J"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacc.2016.10.022","article-title":"Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction.","volume":"69","author":"Ouweneel","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R12-20250729","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19116626","article-title":"Hematologic system dysregulation in critically ill septic patients with anemia-a retrospective cohort study.","volume":"19","author":"Czempik","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5847\/wjem.j.issn.1920-8642.2014.03.006","article-title":"International normalized ratio as a predictor of mortality in trauma patients in India.","volume":"5","author":"Verma","year":"2014","journal-title":"World J Emerg Med"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.advms.2021.07.009","article-title":"INR and COVID-19 severity and mortality: a systematic review with meta-analysis and meta-regression.","volume":"66","author":"Zinellu","year":"2021","journal-title":"Adv Med Sci"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/MEG.0000000000001339","article-title":"Prognostic value of international normalized ratio to albumin ratio among critically ill patients with cirrhosis.","volume":"31","author":"Gao","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1253\/circj.CJ-15-1326","article-title":"Prognostic value of prothrombin time international normalized ratio in acute decompensated heart failure \u2013 a combined marker of hepatic insufficiency and hemostatic abnormality.","volume":"80","author":"Okada","year":"2016","journal-title":"Circ J"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"547","DOI":"10.17219\/acem\/68363","article-title":"Liver dysfunction in sepsis.","volume":"27","author":"Wo\u017anica","year":"2018","journal-title":"Adv Clin Exp Med"},{"key":"R18-20250729","article-title":"Heparin-induced thrombocytopenia under mechanical circulatory support by large impella for acute cardiogenic shock.","volume":"8","author":"Sugimura","year":"2021","journal-title":"J Cardiovasc Dev Dis"},{"key":"R19-20250729","article-title":"Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA-HF.","author":"Adamson","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"7295","DOI":"10.3390\/jcm11247295","article-title":"Impact of lactate on 30-day all-cause mortality in patients with and without out-of-hospital cardiac arrest due to cardiogenic shock.","volume":"11","author":"Rusnak","year":"2022","journal-title":"J Clin Med"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa2101909","article-title":"Angiography after out-of-hospital cardiac arrest without ST-segment elevation.","volume":"385","author":"Desch","year":"2021","journal-title":"N Engl J Med"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI strategies in patients with acute myocardial infarction and cardiogenic shock.","volume":"377","author":"Thiele","year":"2017","journal-title":"N Engl J Med"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1308\/rcsann.2020.0189","article-title":"International normalised ratio as an independent predictor of mortality in limb necrotising fasciitis with sepsis.","volume":"103","author":"Ling","year":"2021","journal-title":"Ann R Coll Surg Engl"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1053\/j.jvca.2021.07.007","article-title":"Precannulation international normalized ratio is independently associated with mortality in veno-arterial extracorporeal membrane oxygenation.","volume":"36","author":"Plazak","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.12998\/wjcc.v9.i25.7405","article-title":"Role of international normalized ratio in nonpulmonary sepsis screening: an observational study.","volume":"9","author":"Zhang","year":"2021","journal-title":"World J Clin Cases"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jcin.2020.02.042","article-title":"Frequency and impact of bleeding on outcome in patients with cardiogenic shock.","volume":"13","author":"Freund","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"Suppl 9","key":"R27-20250729","doi-asserted-by":"crossref","first-page":"8S","DOI":"10.1177\/1076029618806424","article-title":"Disseminated intravascular coagulation: an update on pathogenesis, diagnosis, and therapeutic strategies.","volume":"24","author":"Papageorgiou","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"R28-20250729","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221137893","article-title":"Diagnostic and prognostic significance of the prothrombin time\/international normalized ratio in sepsis and septic shock.","volume":"28","author":"Schupp","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"key":"R29-20250729","first-page":"388","article-title":"Impact of bleeding on mortality in patients with acute myocardial infarction complicated by cardiogenic shock.","volume":"10","author":"Nishihira","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1161\/CIRCULATIONAHA.120.046308","article-title":"Dual antiplatelet therapy after percutaneous coronary intervention and drug-eluting stents: a systematic review and network meta-analysis.","volume":"142","author":"Khan","year":"2020","journal-title":"Circulation"},{"key":"R31-20250729","first-page":"204","article-title":"Risk of bleeding on triple antithrombotic therapy after percutaneous coronary intervention\/stenting: a systematic review and meta-analysis.","volume":"29","author":"Andrade","year":"2013","journal-title":"Can J Cardiol"},{"key":"R32-20250729","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ejhf.872","article-title":"Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).","volume":"19","author":"Harjola","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"R33-20250729","doi-asserted-by":"crossref","first-page":"e004905","DOI":"10.1161\/CIRCHEARTFAILURE.118.004905","article-title":"Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest.","volume":"11","author":"Rao","year":"2018","journal-title":"Circ Heart Fail"},{"key":"R34-20250729","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13613-017-0275-4","article-title":"Systematic review and meta-analysis of complications and mortality of veno-venous extracorporeal membrane oxygenation for refractory acute respiratory distress syndrome.","volume":"7","author":"Vaquer","year":"2017","journal-title":"Ann Intensive Care"},{"key":"R35-20250729","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.tmrv.2014.12.001","article-title":"Extracorporeal membrane oxygenation-hemostatic complications.","volume":"29","author":"Murphy","year":"2015","journal-title":"Transfus Med Rev"},{"key":"R36-20250729","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1097\/CCM.0000000000002995","article-title":"Predicting survival in patients treated with extracorporeal membrane oxygenation after myocardial infarction.","volume":"46","author":"Pabst","year":"2018","journal-title":"Crit Care Med"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T18:02:47Z","timestamp":1753812167000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,1]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001241","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,1]]}}}